Gubra enters into a Market Maker Agreement

MFN Publicerad: 26 Oct 2023 12:35

Gubra announces hereby that is has entered into a Market Maker Agreement with Sydbank A/S to act as liquidity provider on Gubra shares. The agreement is effective as of 26 October 2023 and will remain in force until terminated by either Gubra or Sydbank A/S. The agreement has been concluded with reference to Nasdaq’s Member rules.

About Gubra
Gubra, founded in 2008 in Denmark, listed on NASDAQ Copenhagen in 2023, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organised in two business areas – CRO Services and Discovery & Partnerships (D&P). The two business areas are highly synergistic and create a unique entity capable of generating a steady cash flow from the CRO business while at the same time enjoying biotechnology upside in the form of potential development milestone payments and potential royalties from the D&P business. Gubra has approx. 200 employees and had annual revenue of approx. DKK 200 million in 2022. See www.gubra.dk for more information.

Börskollen

För dig med koll på börsen

Pressmeddelande

Gubra enters into a Market Maker Agreement

Bifogade filer

Nyheter om Gubra

Läses av andra just nu

Om aktien Gubra

Senaste nytt